US · Healthcare

Cabaletta Bio Inc (CABA)

Biotechnology

Cabaletta Bio Inc (CABA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CABA

P/E ratio

25.00

Cabaletta Bio Inc (CABA) — FAQ

What is CABA's P/E ratio?

The price-to-earnings (P/E) ratio for Cabaletta Bio Inc (CABA) is 25.00 (data as of 2026-05-23).

Does Cabaletta Bio Inc pay a dividend?

Dividend yield is not available in the current snapshot for Cabaletta Bio Inc (CABA). Check the MyAverix Finance app for the latest dividend data.

What sector is Cabaletta Bio Inc in?

Cabaletta Bio Inc (CABA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is CABA listed on?

CABA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)